Mood Disorders Overview in Psychopathology
Mood Disorders Overview in Psychopathology
Environmental stress is believed to contribute to the onset of schizophrenia, interacting with genetic predispositions. Predictive factors indicating a risk of developing schizophrenia include a family history of the disorder, substance abuse, having unusual thoughts, higher levels of suspicion, and greater social impairment. These factors, combined with environmental triggers, can increase the likelihood of onset .
Obsessive-compulsive disorder (OCD) is characterized by frequent intrusive thoughts and compulsive actions that the individual recognizes as irrational, yet feels compelled to perform. This awareness and the specific pattern of obsessions and compulsions distinguish OCD from other anxiety disorders. Treatment often includes cognitive-behavioral therapy with exposure and response prevention to break the cycle of compulsion and reduce anxiety, along with medications such as SSRIs to manage symptoms .
The cognitive-behavioral approach explains psychological disorders as stemming from learned, maladaptive thoughts. This implies that treatment could focus on identifying and changing negative thought patterns and behaviors through therapeutic techniques such as cognitive restructuring and behavioral interventions, which aim to alter the thoughts and behavior contributing to the disorder .
Learned helplessness explains depression as resulting from a belief that one is powerless to change their situation, leading to a pervasive sense of hopelessness. This cognitive model suggests that altering these fundamental beliefs and perceptions through cognitive-behavioral therapy can help individuals regain a sense of control and reduce depressive symptoms by changing their cognitive and behavioral responses to stressors .
When diagnosing psychopathology, it is crucial to consider if an individual's behavior deviates from cultural norms, is maladaptive, self-destructive, or causes discomfort and concern. These factors help identify whether an individual's behavior is significantly different from the norm and whether it negatively impacts their life or those around them. This comprehensive assessment ensures a more accurate diagnosis and understanding of the severity of the disorder .
The biological perspective on major depression suggests that a deficiency in monoamines like serotonin may contribute to the disorder, as supported by the effectiveness of selective serotonin reuptake inhibitors like Prozac. This has influenced the treatment approach by focusing on medications that alter neurotransmitter levels, alongside considering genetic factors and life stressors in those genetically at risk for developing depression .
The main symptoms of schizophrenia include delusions, hallucinations, disorganized speech, grossly disorganized or catatonic behavior, and negative symptoms. These differ from general perceptions of mental disorders as they involve significant distortions of reality (e.g., hallucinations) and thought processes, rather than mood or anxiety alone. Schizophrenia's symptoms are also often more severe and debilitating, requiring comprehensive medical and psychological intervention .
Anorexia nervosa is primarily characterized by an excessive fear of gaining weight leading to energy restriction and abnormally low body weight. In contrast, bulimia nervosa involves a cycle of dieting, binge eating, and purging. While both disorders involve an intense focus on body weight and shape, anorexia involves more restrictive behaviors, whereas bulimia involves cyclic behaviors of overeating and compensatory actions like purging .
Genetic factors play a more significant role in the development of bipolar disorder compared to depression. This indicates that for bipolar disorder, treatment strategies may place greater emphasis on genetic predispositions and mood stabilization medications, such as lithium or anticonvulsants, to manage symptoms effectively. Meanwhile, treatment for depression might lean more towards environmental, cognitive, and life stressor management alongside pharmacological interventions .
Dopamine activity in the limbic system, especially the nucleus accumbens, plays a crucial role in the reinforcement and reward pathways associated with addiction. This understanding informs treatment options that target these neural pathways, such as medications to modulate dopamine activity, as well as behavioral interventions focused on altering the environmental and social triggers that lead to substance use .